Zosano Pharma Statistics
Share Statistics
Zosano Pharma has 0
shares outstanding. The number of shares has increased by null%
in one year.
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -1.75 and the forward
PE ratio is null.
Zosano Pharma's PEG ratio is
0.04.
| PE Ratio | -1.75 |
| Forward PE | n/a |
| PS Ratio | 67.1 |
| Forward PS | n/a |
| PB Ratio | 1.6 |
| P/FCF Ratio | -1.6 |
| PEG Ratio | 0.04 |
Financial Ratio HistoryEnterprise Valuation
Zosano Pharma has an Enterprise Value (EV) of 51.11M.
| EV / Sales | 65.1 |
| EV / EBITDA | -1.83 |
| EV / EBIT | -1.85 |
| EV / FCF | -1.55 |
Financial Position
The company has a current ratio of 1.04,
with a Debt / Equity ratio of 0.29.
| Current Ratio | 1.04 |
| Quick Ratio | 1.04 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | -0.34 |
| Debt / FCF | -0.29 |
| Interest Coverage | -157.33 |
Financial Efficiency
Return on Equity is -91.32% and Return on Invested Capital is -70.49%.
| Return on Equity | -91.32% |
| Return on Assets | -62.23% |
| Return on Invested Capital | -70.49% |
| Revenue Per Employee | $19,625 |
| Profits Per Employee | $-752,850 |
| Employee Count | 40 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 189K |
| Effective Tax Rate | -0.63% |
Stock Price Statistics
The stock price has increased by 0.43% in the
last 52 weeks. The beta is 3.29, so Zosano Pharma's
price volatility has been higher than the market average.
| Beta | 3.29 |
| 52-Week Price Change | 0.43% |
| 50-Day Moving Average | 1.58 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 26.22 |
| Average Volume (20 Days) | 5,363,116 |
Income Statement
In the last 12 months, Zosano Pharma had revenue of 785K
and earned -30.11M
in profits. Earnings per share was -0.27.
| Revenue | 785K |
| Gross Profit | -11K |
| Operating Income | -29.74M |
| Net Income | -30.11M |
| EBITDA | -27.98M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.27 |
Full Income StatementBalance Sheet
The company has 11.04M in cash and 9.48M in
debt, giving a net cash position of 1.56M.
| Cash & Cash Equivalents | 11.04M |
| Total Debt | 9.48M |
| Net Cash | 1.56M |
| Retained Earnings | -362.12M |
| Total Assets | n/a |
| Working Capital | n/a |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -27.59M
and capital expenditures -5.42M, giving a free cash flow of -33.01M.
| Operating Cash Flow | -27.59M |
| Capital Expenditures | -5.42M |
| Free Cash Flow | -33.01M |
| FCF Per Share | -0.29 |
Full Cash Flow StatementMargins
Gross margin is -1.4%, with operating and profit margins of -3788.03% and -3836.18%.
| Gross Margin | -1.4% |
| Operating Margin | -3788.03% |
| Pretax Margin | -3812.1% |
| Profit Margin | -3836.18% |
| EBITDA Margin | -3564.97% |
| EBIT Margin | -3788.03% |
| FCF Margin | -4205.48% |
